Spotlight
Clinical
CME
Partners
Accommodating lens available in 0.25-D steps
Aliso Viejo, CA-The FDA has given Eyeonics Inc. approval to market its Crystalens accommodating IOL in quarter-diopter steps. The approval makes eyeonics the first U.S. company to launch 0.25-D IOLs, the company said. The lenses were made available Nov. 1 to credentialed Crystalens surgeons.
Related Videos
Related Content
Pinpointing neurologic dysfunction in fundus photographs using deep learning analysis
March 26th 2023
Pinpointing neurologic dysfunction in fundus photographs using deep learning analysis
March 26th 2023
